EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Biomimetic delivery of a STING agonist via tumor antigen-primed dendritic cell membrane nanovesicles for bladder cancer immunotherapy

Xianlu Zhang, Peng Xin, Yang Du, Ran Wang, Yutao Wang, Jianbin Bi, Yang Liu

Materials Today Bio · 2026-08 · 39 · 103333

DOI: 10.1016/j.mtbio.2026.103333 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Materials Today Bio, 2026-08. Verfasst von Xianlu Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The First Hospital of China Medical University, Shenyang, Liaoning, 110001, China. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

STING agonists hold considerable promise for cancer immunotherapy, but their therapeutic efficacy is often limited by poor cellular delivery, rapid systemic clearance, and insufficient activation of antigen-presenting cells. Here, we report an engineered dendritic cell membrane-derived nanovesicle platform (Ag-DCNV-STINGa) for biomimetic delivery of a STING agonist in bladder cancer immunotherapy. Generated from tumor antigen primed mature human monocyte-derived dendritic cell membranes, Ag-DCNV-STINGa preserves key antigen-presentation features and enables stable surface anchoring of 2'3'-cGAMP. Ag-DCNV-STINGa efficiently enhances STING agonist uptake by dendritic cells, promotes dendritic cell activation, and amplifies downstream T-cell-mediated antitumor immunity in vitro. In immunity humanized NSG mice, systemic administration of Ag-DCNV-STINGa exhibits favorable biosafety, suppresses tumor growth in subcutaneous and orthotopic bladder cancer models, and reduces lung metastatic burden. Mechanistically, Ag-DCNV-STINGa reshapes the tumor immune microenvironment by enhancing immune cell infiltration, sustaining interferon-associated immune activation, and promoting the formation of tertiary lymphoid structure-like immune aggregates. Together, these findings establish Ag-DCNV-STINGa as a biomimetic immunoengineering platform that integrates dendritic cell membrane functionality, tumor antigen information, and STING pathway activation to potentiate antitumor immunity. This strategy provides a promising approach for bladder cancer immunotherapy and may offer a broadly applicable framework for the delivery of innate immune agonists in cancer treatment.

Schlagwörter

Stichwörter der Autor:innen

Biomimetic nanoplatformBladder cancerCancer immunotherapyDendritic cell membrane nanovesiclesSTING agonistTumor antigen priming

Autor:innen und Institutionen

  • Department of Urology, The First Hospital of China Medical University, Shenyang, Liaoning, 110001, China.
  • Mater Research Institute, The University of Queensland, Brisbane, QLD, 4102, Australia.
  • Institute of Chemical Biology, Shenzhen Bay Laboratory, Shenzhen, 518132, China.
  • Department of Urology, Peking Union Medical Collage Hospital, Beijing, China.

Zitieren

APA

Zhang, X., Xin, P., Du, Y., Wang, R., Wang, Y., Bi, J., & Liu, Y. (2026). Biomimetic delivery of a STING agonist via tumor antigen-primed dendritic cell membrane nanovesicles for bladder cancer immunotherapy. Materials Today Bio, 39, 103333. https://doi.org/10.1016/j.mtbio.2026.103333

Vancouver

Zhang X, Xin P, Du Y, Wang R, Wang Y, Bi J, et al. Biomimetic delivery of a STING agonist via tumor antigen-primed dendritic cell membrane nanovesicles for bladder cancer immunotherapy. Materials Today Bio. 2026;39:103333. doi:10.1016/j.mtbio.2026.103333

BibTeX
@article{Zhang2026,
  author = {Zhang, Xianlu and Xin, Peng and Du, Yang and Wang, Ran and Wang, Yutao and Bi, Jianbin and Liu, Yang},
  title = {Biomimetic delivery of a STING agonist via tumor antigen-primed dendritic cell membrane nanovesicles for bladder cancer immunotherapy},
  journal = {Materials Today Bio},
  year = {2026},
  volume = {39},
  pages = {103333},
  doi = {10.1016/j.mtbio.2026.103333}
}
Kostenlos starten →